American pharmaceutical and biotechnology company Moderna Inc. (MRNA: NASDAQ) expects to launch a single-dose COVID-19 vaccine in India next year,

Moderna is also in talks with other Indian companies such as multinational pharmaceutical company Cipla, sources said on Tuesday.

It was discussed that Moderna doesn’t have surplus vaccines to share in 2021 and that it plans to launch its single-dose vaccine for the Indian market only in 2022, for which, they are in discussion with Cipla and other Indian companies, a source said.

It is learnt that Cipla has already evinced interest in procuring 5 crore doses from Moderna for 2022 and has requested confirmation from the central government in respect of stability in regulatory requirements/policy regime.

The Health Ministry has also been asked to take an early decision on Cipla’s request regarding support required by them for procurement of Moderna vaccines.

Source: https://indianexpress.com/article/india/moderna-vaccine-in-india-next-year-pfizer-ready-with-5-crore-doses-7330170/